GlassScriptPhysician profile
Stephen Rodes Brown
NPI 1053842344
$859.21
in general payments reported to CMS, 2019-2025
9 companies · $486 in 2025
The $486 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $19.24 · 2024: $202 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $325.63 | 2022-2025 | Flowtriever |
| Argon Medical Devices, INC. | $185.92 | 2024 | Clot Management |
| Sirtex Medical INC | $147.26 | 2025 | Lava Les (Liquid Embolic System) |
| Angiodynamics, INC. | $64.73 | 2025 | Alphavac |
| Boston Scientific Corporation | $47.68 | 2025 | Obsidio |
| Microvention, INC. | $32.93 | 2025 | Sofia 6f-131cm Str, Web Aneurysm Embolization System, Azur Cx Detachable |
| Medtronic, INC. | $20.09 | 2022 | |
| Edwards Lifesciences Corporation | $19.24 | 2023 | Sapien 3 Ultra Resilia |
| Galvanize Therapeutics, INC | $15.73 | 2024 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.